BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33401595)

  • 1. Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
    Fattizzo B; Serpenti F; Barcellini W; Caprioli C
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401595
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological derangement in hypocellular myelodysplastic syndromes.
    Serio B; Risitano A; Giudice V; Montuori N; Selleri C
    Transl Med UniSa; 2014 Jan; 8():31-42. PubMed ID: 24778996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).
    Votavova H; Belickova M
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flared inflammatory episode transforms advanced myelodysplastic syndrome into aplastic pancytopenia: A case report and literature review.
    Ju B; Xiu NN; Xu J; Yang XD; Sun XY; Zhao XC
    World J Clin Cases; 2023 Jun; 11(17):4105-4116. PubMed ID: 37388797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
    Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
    Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
    Durrani J; Maciejewski JP
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
    Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoplastic form of myelodysplastic neoplasm.
    Votavová H; Lenertová Z; Votava T; Beličková M
    Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of clonal cytogenetic abnormalities in aplastic anemia.
    Maciejewski JP; Selleri C
    Leuk Lymphoma; 2004 Mar; 45(3):433-40. PubMed ID: 15160903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
    Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
    Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome.
    Bono E; McLornan D; Travaglino E; Gandhi S; Gallì A; Khan AA; Kulasekararaj AG; Boveri E; Raj K; Elena C; Ireland RM; Bianchessi A; Jiang J; Todisco G; Ferretti VV; Cazzola M; Marsh JCW; Malcovati L; Mufti GJ
    Leukemia; 2019 Oct; 33(10):2495-2505. PubMed ID: 30940907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
    Karantanos T; DeZern AE
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocellular myelodysplastic syndromes (MDS): new proposals.
    Tuzuner N; Cox C; Rowe JM; Watrous D; Bennett JM
    Br J Haematol; 1995 Nov; 91(3):612-7. PubMed ID: 8555063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    Barrett J; Saunthararajah Y; Molldrem J
    Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.
    Afable MG; Wlodarski M; Makishima H; Shaik M; Sekeres MA; Tiu RV; Kalaycio M; O'Keefe CL; Maciejewski JP
    Blood; 2011 Jun; 117(25):6876-84. PubMed ID: 21527527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoplastic myelodysplastic syndrome.
    Nand S; Godwin JE
    Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
    Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
    Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.